Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

A review of five non-Copilot AI coding assistants available in the Visual Studio Marketplace that support Visual Studio 2026 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A hands-on comparison shows how Cursor, Windsurf, and Visual Studio Code approach text-to-website generation differently once ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...

North Korean hackers abuse Visual Studio Code task files in fake job projects to deploy backdoors, spyware, and crypto miners ...

CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Lakshmi Varanasi Every time Lakshmi publishes a story, you’ll get an alert straight to your ...

Welcome to the ME 270 course website for the Spring 2026 term. The material on this site is a complement to the lecture book for the course. And, all material here is accessible without the need to ...